HHTM's mission is to bridge the knowledge gaps in treating hearing loss by providing timely information and lively insights to anyone who cares about hearing loss. Our contributors and readers are drawn from many sectors of the hearing field, including practitioners, researchers, manufacturers, educators, and, importantly, consumers with hearing loss and those who love them.
Featured image for “Second Future of Hearing Healthcare Conference to Take Place May 24-26, 2022”
Apr. 22, 2022

Second Future of Hearing Healthcare Conference to Take Place May 24-26, 2022

HHTM
Hearing Health & Technology Matters (HHTM) is pleased to announce the second annual Future of Hearing Healthcare Conference will take place from May 24-26, 2022. The three-day virtual event, hosted by HHTM, will provide attendees with insights into the latest treatment and technologies that will have a hand in shaping the future of hearing care. “The Future of Hearing Healthcare
Featured image for “Cell Therapy Treatment for Hearing Loss: Interview with Lineage Cell Therapeutics CEO, Brian Culley”
Apr. 20, 2022

Cell Therapy Treatment for Hearing Loss: Interview with Lineage Cell Therapeutics CEO, Brian Culley

HHTM
This week we tackle cell and gene therapy for hearing loss. To help us better understand the potential of allogeneic cell therapy we asked Brian Culley, CEO of Lineage Cell Therapeutics to describe how it works and how these types of pharmacologic treatments could stand side-by-side existing treatments such as hearing aids and cochlear implants. Be sure to subscribe to
Featured image for “Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Hearing Loss Patients”
Apr. 20, 2022

Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Hearing Loss Patients

HHTM
SAN DIEGO, CALIFORNIA — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced positive top-line results from the Phase 2a clinical trial of OTO-413 in subjects with hearing loss. The randomized, double-blind, placebo-controlled trial demonstrated that a single intratympanic injection of 0.3 mg OTO-413, a sustained exposure formulation of brain-derived neurotrophic
Featured image for “Challenges and Blessings of Navigating Hearing Loss in Children: Interview with Heather Thomson”
Apr. 19, 2022

Challenges and Blessings of Navigating Hearing Loss in Children: Interview with Heather Thomson

HHTM
This week, celebrity influencer and hearing advocate, Heather Thomson sits down with Shari Eberts to address the challenges and blessings of navigating hearing loss in children and empowering her son to own his hearing health as he enters adulthood. Heather recently partnered with ReSound to help raise awareness of the hearing loss stigma surrounding young adults and adolescents. During her
Featured image for “Where’s the Hearing Loss? My Experience at an Aging Conference”
Apr. 18, 2022

Where’s the Hearing Loss? My Experience at an Aging Conference

HHTM
“How does your program or service for older adults include hearing loss?” we asked each exhibitor at American Aging Society’s 2022 On Aging Conference. Most of the time we were met with silence, followed by, “That’s an interesting question. Well, we have links on our website to hearing loss resources for people, but it’s not a major part of what
Featured image for “Lucid Hearing Announces Launch of New fio Hearing Aids”
Apr. 14, 2022

Lucid Hearing Announces Launch of New fio Hearing Aids

HHTM
FORTWORTH, TEXAS — Lucid Hearing has announced the launch of fio, the company’s smallest in-canal, rechargeable hearing aid. “Fio is focused on delivering the most comfortable fit and function for the active individual who is looking to maximize every moment of their lives. Hearing health is a right of every individual and our goal at Lucid Hearing is to simply
Featured image for “Latest Hearing Loss Research Highlights Need for Earlier Intervention”
Apr. 14, 2022

Latest Hearing Loss Research Highlights Need for Earlier Intervention

HHTM
By Brian Taylor, AuD, Editor-at-Large It is recognized that untreated hearing loss negatively affects quality of life, and is often linked to depression, social isolation and cognitive decline. More recently, it has emerged that the consequences of untreated hearing loss develop in individuals with normal audiograms.  Building on their previous work linking subclinical hearing loss to both depression and cognitive
Featured image for “Tinnitus: Advances in Prevention, Assessment, and Management”
Apr. 14, 2022

Tinnitus: Advances in Prevention, Assessment, and Management

HHTM
SAN DIEGO, CALIFORNIA — The term ‘tinnitus’ is searched over 110,000+ times every month. Unfortunately, much of the information readily available through internet searches is inaccurate, whereas most evidence-based information is only available through peer-reviewed journal articles often containing dense scientific jargon. Tinnitus: Advances in Prevention, Assessment, and Management aims to bridge this gap by providing up-to-date and evidence-based information on
Featured image for “New children’s book author aims to take fierce action against childhood teasing”
Apr. 14, 2022

New children’s book author aims to take fierce action against childhood teasing

HHTM
CROOKSTON, MINNESOTA – When author Becky Cymbaluk was unable to find a suitable book about children with hearing aids for her granddaughter with hearing loss, she decided to write Super Kena – A Girl Made Fierce with Hearing Aids. Addressing Challenges Faced by Children with Disabilities Children with disabilities are two to three times more likely to be picked on
Featured image for “Virtual Facetime with Candidates for President of the American Academy of Audiology”
Apr. 13, 2022

Virtual Facetime with Candidates for President of the American Academy of Audiology

HHTM
If you are a member of the American Academy of Audiology, and you have yet to cast your vote for president-elect, this special episode of This Week in Hearing is well worth your time. Both candidates, Bopanna Ballachanda and Rebekah Cunningham, sat down with TWIH to chat about their career paths and the vision they have for the profession. Be